ID 100884915 © Roxana Gonzalez | Dreamstime.com

By Keaton Brown and Tyler Marr

POSITIVE RESULT

U of S study shows medicinal cannabis oil could be effective for treating children with severe epilepsy

Jul 5, 2019 | 5:00 PM

Preliminary results from a new study out of the University of Saskatchewan showed medicinal cannabis oil containing both cannabidiol (CBD) and a small amount of THC can drastically reduce seizures in a small subgroup of children with severe, drug-resistant epilepsy.

According to research published in Frontiers in Neurology, children in the study who had severe epilepsy experienced an improvement in quality of life after taking low doses of the medicinal cannabis oil.

The study was designed to test the effects of oil with 95 per cent CBD, a chemical that does not create a high, and five per cent THC, an intoxicating substance in large doses.

The dosage escalation study saw researchers measure levels of CBC and THC in the blood of patients, something never done before in similar studies.

Patients had their dosage of oil increased in scheduled amounts every month and researchers monitored side effects to gain a better understanding of appropriate dosages.

Health

First Canadian case of more severe mpox strain confirmed in Manitoba

3h ago

Mail

Canada Post reports $315M Q3 loss, compared with $290M loss a year earlier

23h ago

opportunities

LLRIB teen returns from immersive culinary trip in Vancouver

Nov 20, 2024

Three of seven children in the study — which has 19 in total — stopped having seizures altogether. The average patient saw a 75 per cent reduction in seizures, while two saw under a 50 per cent reduction. The results are early and very preliminary.

The study found that most children had a reduction in seizures with a twice daily dose of CBD totalling five to six milligrams of cannabis extract per kilogram of weight per day. By the time the dosage reached 10 to 12 mg/kg per day, all children experienced a reduction in their seizures, most by more than 50 per cent.

Alongside this, the team was able to scientifically dispel some of the concerns about how to dose CBD oil and the possibility of them causing a high in children.

Dr. Richard Huntsman, a pediatric neurologist at the Royal University Hospital, said the results are encouraging as they could open up possible treatment options for children who have failed to respond to traditional medications and face severe seizures.

“What we have been able to do with this study is provide a dosage guideline for physicians,” he said. “We have been able to show by using THC, levels in the blood and observing the children closely. We saw no signs of THC intoxication, even on the highest doses we used.”

He said accessing pharmaceutical grade CBD oils can be difficult for many families as they are quite expensive and many physicians are reluctant to prescribe cannabis herbal extracts as there is no data about dosage amounts and concerns about getting high from the THC.

Dr. Huntsman, however, said he would not recommend this treatment as a first line medication for all children with epilepsy, only those who have failed to be remedied on multiple medications and have severe pediatric epilepsy.

Prince Albert’s Allyssa Sanderson’s eight-year-old son Ben was one of the participants in the study.

When Ben was two, he was diagnosed with Lennox-Gastaut syndrome, a severe form of epilepsy. Despite trying different types of treatments, Ben’s seizures remained unpredictable. The family considered this trial as a last resort for Ben.

Once Ben started taking CBD, he began showing improvements in his seizure frequency and then became seizure-free during the study.

“I was seeing the change in Ben every single day. I was thankful as I watched his little personality come out. He was back to his silly self that I hadn’t seen in years. He was stronger. I believe this research is one of the greatest things to happen for kids with epilepsy,” Sanderson said in a media release from the university.

Next up, the doctor said, are plans to work collaboratively with the national Canadian Childhood Cannabinoid Clinical Trial Network on a large scale international trial.

Dr. Huntsman is proud of the fact the study was a Saskatchewan initiative, developed by teams at the U of S, funded heavily by the Jim Pattison Children’s Hospital Foundation.

“These guys have been so supportive and without their support we would not have been able to do this,” he said.

Five years ago when he approached the group for financial assistance, he said many organizations would have called him crazy for wanting to conduct cannabis research on children.

“But they had the courage to and foresight to listen to what we were saying,” he said. “These are desperate families and we have to do something to help them and they had the courage to do that.”

The research team included neurologists, psychologists and pharmacologists from the university’s Cannabinoid Research Initiative of Saskatchewan. Funding also came from the Saskatchewan Health Research Foundation, the Durwood Seafoot Estate and the Savoy Foundation.

—

keaton.brown@jpbg.ca, tyler.marr@jpbg.ca

On Twitter: @battlefordsnow, @JournoMarr